Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

J&J’s Darzalex nets first self-administered cancer injectable approval - Pharmaceutical Technology

Summary by Pharmaceutical-technology.com
Analysts say that the approval of J&J's Darzalex in the at-home setting could enhance the drug's accessibility and uptake in multiple myeloma
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

pharmaceutical-technology.compharmaceutical-technology.com

J&J’s Darzalex nets first self-administered cancer injectable approval - Pharmaceutical Technology

Analysts say that the approval of J&J's Darzalex in the at-home setting could enhance the drug's accessibility and uptake in multiple myeloma

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

pharmaceutical-technology.com broke the news in on Friday, March 27, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Johnson & Johnson icon

Johnson & Johnson

Cancer icon

Cancer

United States icon

United States

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal